RecommendsPositive OutlookApproves of CEO
- Work/Life Balance
- Culture & Values
- Career Opportunities
- Comp & Benefits
- Senior Management
I have been working at FibroGen full-time (More than 8 years)
All three core programs come out of original and exciting work done by the company. The anemia platform is ground-breaking and represents an opportunity to reach and help so many people. The fibrosis/cancer program could mean potential treatment for people who currently have no options. This is real science with real potential.
FibroGen is its own worst enemy. The science is great and the CEO is charismatic, innovative, and has the loyalty of a solid core of high performers . However, some people in upper management are not qualified to hold the positions they have. Hopefully, an IPO will be a chance to tighten up an otherwise good team.
Advice to Management
Pay attention to your top performers, and don't waste company resources and space on those who consistently underperform or don't know how to be professional, especially when this means more work gets dumped on the people who do know how to do their jobs. Try to limit work to standard hours and not expect people to work at all hours and on weekend.
Getting an Interview
Getting an Interview
- Accepted OfferPositive ExperienceAverage Interview
I applied through a staffing agency. The process took 4+ weeks. I interviewed at FibroGen in May 2014.
The interview process was very quick. I had a phone interview with the QC Senior Director and my onsite interview was scheduled the same day. A lot of technical questions and some behavioural questions. The hiring process took 1 month.
- What would your previous supervisor say about you? Answer Question
Let us know if we're missing any workplace or industry recognition –
FibroGen is serious about drug discovery and that's no lie. The company is focused on developing and commercializing treatments for fibrosis, anemia, diabetes, and cancer, as well as producing recombinant human collagens and synthetic gelatins. FibroGen has several products in clinical development, including biotechnology (protein-based) and traditional pharmaceutical (chemical-based) candidates that could treat a variety of conditions including diabetic kidney disease, ophthalmic ailments, anemia, and cancer. The company is also researching biologic forms of human ...